A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Type 2 diabetes mellitus (T2DM) has been identified as an independent risk factor for hepatocellular cancer (HCC). However, there are no ideal biomarkers for the surveillance and early detection of HCC in the T2DM population at present. In this study, we aimed to explore novel metabolite biomarkers...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2022-07-01
|
| Schriftenreihe: | Metabolites |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2218-1989/12/7/610 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
